Non-alcoholicfattyliver相关论文
目的:对同步抗感染治疗应用于非酒精性脂肪肝合并幽门螺杆菌感染患者治疗中的可行性展开研究.方法:随机将2020年2月至2021年2月我......
Mori Cortex extract ameliorates nonalcoholic fatty liver disease (NAFLD) and insulin resistance in h
Nonalcoholic fatty liver disease (NAFLD) and type 2 Diabetes Mellitus (T2DM) are highly prevalent diseases and are close......
Ilexgenin A enhances the effects of simvastatin on non-alcoholic fatty liver disease without changes
Cardiovascular disease (CVD) is the most common cause of death in patients with non-alcoholic fatty liver disease (NAFLD......
There is a sex-difference in the disease progression of non-alcoholic fatty liver disease/steatohepatitis(NAFLD/NASH......
目的观察高脂饮食诱导的非酒精性脂肪肝病(NAFLD)大鼠模型血脂及肠道短链脂肪酸的变化，探讨肠道短链脂肪酸改变在NAFLD发病过程中作......
非酒精性脂肪性肝病(NAFLD)是一种常见的但是发病机制尚不十分清楚的全球性疾病.NAFLD的患病率为25％ ～ 30％,其主要的病理改变是肝脏内......
目的 探讨吡格列酮对糖耐量减低合并非酒精性脂肪肝患者血清脂联素变化的影响.方法 吡格列酮组46例糖耐量减低合并非酒精性脂肪肝......
